Jianmin Pharmaceutical Group Co Ltd. Class ASSE: 600976

Announcement on Convening the Performance Briefing in Q3 2025

· Issued by Jianmin Pharmaceutical Group Co Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening the Performance Briefing in Q3 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment